Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-15-000216

CEO gave up 34,261 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEWIS JONATHAN CEO 2014-12-30 Shares withheld for taxes −34,261 $5.03 $172,333 744,145 D
Derivatives
LEWIS JONATHAN CEO 2014-12-31 Grant or award · Employee Stock Option (Right to Buy) +350,000 350,000 D
Loading xslF345X03/doc4.xml…